Julie L. Eiseman
- Molecular Biology top 5%
- Oncology top 5%
- Biomaterials top 5%
- Biomedical Engineering top 10%
- Immunology top 10%
- Co-authors
- Merrill J. EgorinErin JosephJoseph M. CoveyRobert A. PariseDorothy L. SentzAlvito P. AlvaresJan H. BeumerDeborah R. Hamburger
- Topics
- Cancer therapeutics and mechanisms (27 papers)Cancer Treatment and Pharmacology (16 papers)Drug Transport and Resistance Mechanisms (11 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Julie L. Eiseman
130 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 2.1k
- Oncology 733
- Biomaterials 344
- Biomedical Engineering 306
- Immunology 302
Countries citing papers authored by Julie L. Eiseman
This map shows the geographic impact of Julie L. Eiseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie L. Eiseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie L. Eiseman more than expected).
Fields of papers citing papers by Julie L. Eiseman
This network shows the impact of papers produced by Julie L. Eiseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie L. Eiseman. The network helps show where Julie L. Eiseman may publish in the future.
Co-authorship network of co-authors of Julie L. Eiseman
This figure shows the co-authorship network connecting the top 25 collaborators of Julie L. Eiseman. A scholar is included among the top collaborators of Julie L. Eiseman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie L. Eiseman. Julie L. Eiseman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 42 | |
| 2 | 18 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 6 | |
| 7 | 23 | |
| 8 | 4 | |
| 9 | 12 | |
| 10 | 23 | |
| 11 | 10 | |
| 12 | 9 | |
| 13 | A physiologically-based pharmacokinetic (PBPK) model of docetaxel in SCID mice bearing SKOV3 human ovarian cancer xenografts | 1 |
| 14 | Plasma, tissue and tumor disposition of STEALTH® liposomal CKD-602 (S-CKD602) and non-liposomal CKD-602, a camptothecin analogue, in mice bearing A375 human melanoma xenografts | 3 |
| 15 | 25 | |
| 16 | 13 | |
| 17 | 13 | |
| 18 | 40 | |
| 19 | Physical growth and endocrine correlates of blood pressure variation among bundi gende speaking adolescents of papua new guinea | 2 |
| 20 | 26 |
About Julie L. Eiseman
Julie L. Eiseman is a scholar working on Oncology, Pharmacology and Cancer Research, having authored 131 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (27 papers), Cancer Treatment and Pharmacology (16 papers) and Drug Transport and Resistance Mechanisms (11 papers). The work is most often cited by research in Molecular Biology (2.1k citations), Oncology (733 citations) and Biomaterials (344 citations). Julie L. Eiseman has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Merrill J. Egorin, Erin Joseph, Joseph M. Covey, Robert A. Parise, Dorothy L. Sentz, Alvito P. Alvares, Jan H. Beumer, Deborah R. Hamburger, Donald J. Creighton and Jianxia Guo. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.